Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07828444 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

New Zealand Blackcurrant and Recovery in Elite Taekwondo

Study acronym: NZBC-TAE
StatusCompleted
PhaseNot applicable
Started2023-12-01
View on ClinicalTrials.gov ↗
This randomized, double-blind, placebo-controlled trial evaluated the effects of short-term supplementation with anthocyanin-rich New Zealand blackcurrant (NZBC) extract on exercise-induced muscle damage, oxidative stress, antioxidant status, inflammatory responses, and perceived muscle soreness in elite male taekwondo athletes. Thirty national-level male taekwondo athletes were enrolled and randomly assigned in a 1:1 ratio to receive either NZBC extract (CurraNZ®, UK; 600 mg/day providing approximately 210 mg anthocyanins) or a matched placebo for 7 days. Blood samples and muscle soreness ratings were collected at baseline, immediately after exercise, 24 hours after exercise, and after 7 days. The primary outcome was plasma creatine kinase (CK). Secondary outcomes included reactive oxygen species (ROS), total antioxidant capacity (TOAC), protein carbonyls, inflammatory cytokines (IL-6, TNF-α, and IL-10), and perceived muscle soreness assessed using a visual analog scale (VAS). The study was approved by the Biruni University Clinical Research Ethics Committee (No. 2015-KAEK-80-23-33; December 22, 2023). Written informed consent was obtained from all participants.
Trial Details
NCT Number NCT07828444
Lead Sponsor Hacettepe University
Conditions Exercise-induced Muscle Damage, Oxidative Stress, Inflammation, Recovery After Exercise
Enrollment 29 participants
Start Date 2023-12-01
Primary Completion 2024-06-01 (estimated)
Study Completion 2024-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-18